| 2023 | 2022 | |||||||
| Revenues | $ | - | $ | 37,500 | ||||
| Cost of sales | - | 18,644 | ||||||
| Gross profit | - | 18,856 | ||||||
| Operating Costs and Expenses | ||||||||
| Selling, general and administrative expenses | 1,827,729 | 2,196,331 | ||||||
| Research and development expenses | 598,810 | 624,564 | ||||||
| Total Operating Expenses | 2,426,539 | 2,820,895 | ||||||
| Loss from Operations | (2,426,539) | (2,802,039) | ||||||
| Other income (expenses) | ||||||||
| Interest expense | (40,512) | (17,022) | ||||||
| Interest expense – related party | (75,684) | (61,823) | ||||||
| Loss on settlement of debt | (80,532) | (209,598) | ||||||
| Other income | - | 1,402,981 | ||||||
| Total Other Income (Expense) | (196,728) | 1,114,538 | ||||||
| Income tax expense | - | - | ||||||
| Net Loss | $ | (2,623,267) | $ | (1,687,501) | ||||
| Net Loss per common share: | ||||||||
| Basic and diluted | $ | (0.01) | $ | (0.01) | ||||
| Weighted average number of shares outstanding | 239,080,282 | 229,718,142 | ||||||
